Longevity Health Holdings, Inc. (NASDAQ:XAGE – Get Free Report)’s stock price rose 9.3% during mid-day trading on Thursday . The company traded as high as $0.3390 and last traded at $0.3390. Approximately 22,276 shares traded hands during mid-day trading, an increase of 656% from the average daily volume of 2,948 shares. The stock had previously closed at $0.3102.
Longevity Health Trading Up 9.3%
The business has a 50-day moving average price of $0.34 and a 200 day moving average price of $0.36. The stock has a market capitalization of $604,098.00, a P/E ratio of -0.08 and a beta of 0.37.
Longevity Health Company Profile
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Featured Stories
- Five stocks we like better than Longevity Health
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Longevity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longevity Health and related companies with MarketBeat.com's FREE daily email newsletter.
